Katherine A High's Net Worth
$51.8 Million
Who is Katherine A High?
Katherine A High has an estimated net worth of $51.8 Million. This is based on reported shares across multiple companies, which include INCYTE CORP, CRISPR Therapeutics AG, and Spark Therapeutics, Inc..
SEC CIK
Katherine A High's CIK is 0001631248
Past Insider Trading and Trends
2017 was Katherine A High's most active year for acquiring shares with 12 total transactions. Katherine A High's most active month to acquire stocks was the month of May. 2017 was Katherine A High's most active year for disposing of shares, totalling 25 transactions. Katherine A High's most active month to dispose stocks was the month of February. 2019 saw Katherine A High paying a total of $7,186,317.80 for 267,624 shares, this is the most they've acquired in one year. In 2019 Katherine A High cashed out on 726,082 shares for a total of $46,009,974.02, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
INCYTE CORP (INCY) Snapshot price: $57.625
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +35.41% | 2.83K |
—
|
—
| 10.82K |
Jun 12
| |||
Form 4
| +45.65% | 2.5K |
—
|
—
| 7.99K |
Jun 14
| |||
Form 4
| +64.11% | 2.14K |
—
|
—
| 5.49K |
Jun 15
| |||
Form 4
| +135.33% | 1.92K |
—
|
—
| 3.34K |
May 26
| |||
Form 4
| +922.30% | 1.28K |
—
|
—
| 1.42K |
May 26
| |||
Form 4
|
∞
| 139 |
—
|
—
| 139 |
Mar 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CRISPR Therapeutics AG (CRSP) Snapshot price: $65.795
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Spark Therapeutics, Inc. No price found
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -278.83K |
$114.50 | -$31,926,493.00 |
0
|
Dec 17
| |||
Form 4
| +30.01% | 64.37K |
$75.73 | -$6,829,948.94 | 278.83K |
Mar 21
| |||
Form 4
| +1.42% | 3.01K |
$45.08 | -$67,214.28 | 214.47K |
Jan 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 15
| |||
Form 4
| +0.69% | 1.46K |
$50.55 | -$39,985.05 | 211.46K |
Jan 18
| |||
Form 4
|
—
|
0
|
$37.39 | -$339,340.00 | 210K |
Scheduled
|
Nov 28
| ||
Form 4
|
—
|
0
|
$43.38 | -$399,250.00 | 210K |
Scheduled
|
Oct 31
| ||
Form 4
|
—
|
0
|
$44.81 | -$413,552.68 | 210K |
Scheduled
|
Sep 26
| ||
Form 4
|
—
|
0
|
$41.85 | -$768,041.29 | 210K |
Scheduled
|
Aug 29
| ||
Form 4
|
—
|
0
|
$37.99 | -$690,790.00 | 210K |
Scheduled
|
Jul 25
| ||
Form 4
|
—
|
0
|
$32.21 | -$575,100.00 | 210K |
Scheduled
|
Jun 27
| ||
Form 4
|
—
|
0
|
$31.73 | -$565,500.00 | 210K |
Scheduled
|
Jun 19
| ||
Form 4
|
—
|
0
|
$30.76 | -$819,150.00 | 210K |
Scheduled
|
Apr 28
| ||
Form 4
|
—
|
0
|
$29.39 | -$778,257.10 | 210K |
Scheduled
|
Apr 24 - Apr 25
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 18
| |||
Form 4
| -4.55% | -10.00K |
$60.30 | -$603,000.00 | 210K |
Scheduled
|
Nov 14
| ||
Form 4
| -4.35% | -10.00K |
$60.37 | -$603,735.00 | 220K |
Scheduled
|
Sep 15
| ||
Form 4
| -4.17% | -10.00K |
$62.76 | -$627,553.30 | 230K |
Scheduled
|
Aug 15
| ||
Form 4
| -0.78% | -1.89K |
$60.00 | -$113,400.00 | 240K |
Scheduled
|
Aug 10
| ||
Form 4
| -0.21% | -500.00 |
$60.24 | -$30,120.00 | 241.89K |
Scheduled
|
Aug 4 - Aug 8
| ||
Form 4
| -6.77% | -17.61K |
$60.02 | -$1,056,879.66 | 242.39K |
Scheduled
|
Aug 1 - Aug 3
| ||
Form 4
| -3.70% | -10.00K |
$54.00 | -$540,000.00 | 260K |
May 24
| |||
Form 4
| -3.57% | -10.00K |
$54.42 | -$544,249.00 | 270K |
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
| -3.45% | -10.00K |
$55.31 | -$553,100.00 | 280K |
Scheduled
|
Dec 1
| ||
Form 4
| -3.33% | -10.00K |
$53.77 | -$537,700.00 | 290K |
Scheduled
|
Nov 16
| ||
Form 4
| -11.76% | -40.00K |
$49.01 | -$1,960,300.00 | 300K |
Oct 13 - Oct 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 16
| |||
Form 4
|
∞
| 700 |
$23.00 | $16,100.00 | 700 |
Feb 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||